Unusual move sees iconic motorcycle manufacturer bring claim against retailer at UK High Court | 1mo
Unusual move sees iconic motorcycle manufacturer bring claim against retailer at UK High Court | 1mo
Team moves over from Lerner David strengthening medical device practice | 1mo
Herbert Smith Freehills lawyers Sebastian Moore, Frederic Chevallier and Rachel Montagnon look back on the Unified Patent Court’s maiden year | 1mo
Patent holding company Sun Patent Trust is asking the Paris Judicial Court to determine a global FRAND rate, while India will examine infringement | 1mo
Decision upholds earlier ruling revoking patent covering the drug Xarelto, further clearing way for generic manufacturers to enter the lucrative market | 1mo
Three-partner hire bolsters disputes firm’s patent litigation practice in tech sector | 1mo
Closely watched decision on assessing obviousness in dispute featuring General Motors dubbed blow to design owners | 1mo
Balancing confidentiality and transparency is an evolving landscape for UPC proceedings, writes Mewburn Ellis partner Matthew Naylor | 1mo
Mr Justice Mellor ‘entirely satisfied’ Craig Wright ‘lied to the court extensively and repeatedly’ | 2mos
Directors of defunct fashion business win appeal over lack of evidence they knew about – or turned a blind eye to – trademark infringements | 2mos
Trial lawyer James Sawtelle joins to lead new office in Denver alongside seven commercial and employment litigators and counsellors | 2mos
Uncertainty regarding impact of ruling over work sampled in artist Flo Rida’s music as it relies on a “discovery rule” that could be invalidated in future cases | 2mos
The Baneberry brand sold products infringing the luxury retailer’s IP in pop-up shops and online | 2mos
Led by respected life sciences litigator Siegmund Gutman, the team of 10 move over from Proskauer Rose | 2mos
Düsseldorf local division orders US life sciences company Curio Bioscience to stop selling its products in Germany, France and Sweden in dispute with rival 10x Genomics | 2mos
UK pharmaceutical firm enters the fray in the battle over mRNA technology used to develop blockbuster vaccines | 2mos
The USPTO is leaning on old rules to help govern AI-related patent filings, write Holland & Hart partners Philip Harris and Nathan Mutter | 2mos
Trimmed down cohort brings firm closer to goal of 30% female partnership by 2025 | 2mos
Trial expected next January as judges say appeal bid ‘does not raise an arguable question of law’ over group claims | 2mos
Ngai Zhang and Drew Schulte move over from Perkins Coie to the AmLaw 100 firm as it seeks to bolster its innovative technology capabilities | 2mos